The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE
Recruiting
N/A
Interventional Study
Barrett's Esophagus
Intestinal Metaplasia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 165 (estimated)
- Sponsor
- E-DA Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Detections of goblet cells and dysplasia are crucial for diagnosis and determining the surveillance program of Barrett's esophagus (BE). However, the optimal biopsy numbers and their yield rates of intestinal metaplasia (IM) and dysplasia are still uncertain, especially in Asia. The aim of this study was to determine the optimal biopsy protocol of BE.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults with columnar-lined esophagus
Exclusion Criteria:
* A prior history of endoscopic treatment for Barrett's Esophagus
* A prior history of upper gastrointestinal malignancy
* A prior history of total or subtotal gastrectomy
* Esophageal varices noted during the procedur…
Contacts